...
首页> 外文期刊>Kidney international. >Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock
【24h】

Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock

机译:在存在和不存在休克的情况下,肌红蛋白会耗尽肾腺嘌呤核苷酸库

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock. To assess whether myoglobin adversely affects renal adenylate pools, rats were infused with purified myoglobin (50 mg/100 g body wt) for two hours and renal ATP, ADP, and AMP levels were measured in the absence of shock, after 25 minutes of hemorrhagic shock (55 to 60 mm Hg) or 30 minutes post-recovery. In the absence of shock, myoglobin lowered ATP by 24% (assessed 65 min post-infusion) without affecting renal blood flow (RBF). This effect was completely blocked by deferoxamine (DFO) treatment and it could not be reproduced by ribonuclease infusion (a non-Fe containing, but filtered, protein). Myoglobin + shock caused a three- to fourfold greater decline in ATP than did shock alone despite comparable RBFs. Shock plus myoglobin, but neither one alone, induced substantial S1/S2 proximal tubular morphologic damage and a severe reduction in creatinine clearance, confirming synergistic injury. Ribonuclease completely reproduced myoglobin's effect on shock-induced adenylate profiles. DFO hydroxyl radical scavenger therapy (Na benzoate) did not block the myoglobin shock effect on adenylate pools Post-shock adenylate recovery was not compromised by myoglobin pre-treatment. If renal artery occlusion (RAO), rather than shock, was used as the ischemic challenge, myoglobin had no discernible impact on adenine nucleotide content. This study concludes that: 1) myoglobin modestly lowers baseline adenylate pools due to an Fe dependent mechanism; 2) myoglobin drastically accentuates shock-induced adenylate depletion by a non-hemodynamicon-Fe dependent mechanism; 3) myoglobin nephrotoxicity cannot be attributed solely to tissue iron loading; and 4) the RAO model can completely mask important influences on ischemic cellular energetics. This needs to be recognized when the RAO model is used to study ischemic ARF.
机译:在存在和不存在休克的情况下,肌红蛋白会耗尽肾脏的腺嘌呤核苷酸库。为了评估肌红蛋白是否对肾脏腺苷酸池有不利影响,在出血25分钟后,在无休克的情况下,向大鼠输注纯净的肌红蛋白(50 mg / 100 g体重),历时2小时,并测量了肾脏ATP,ADP和AMP的水平。恢复后30分钟(55至60 mm Hg Hg)冲击。在没有休克的情况下,肌红蛋白将ATP降低了24%(输注后65分钟评估),而不会影响肾血流量(RBF)。该作用已被去铁胺(DFO)处理完全阻断,并且不能通过核糖核酸酶输注(不含铁但已过滤的蛋白质)重现。尽管有相当的RBF,但肌红蛋白+休克导致的ATP下降比仅休克增加了三到四倍。休克加肌红蛋白,但没有一个单独引起,引起实质性的S1 / S2近端肾小管形态学损害和肌酐清除率的严重降低,证实了协同损伤。核糖核酸酶完全重现了肌红蛋白对休克诱导的腺苷酸谱的影响。 DFO羟基自由基清除剂治疗(苯甲酸钠)没有阻止肌红蛋白对腺苷酸池的休克作用。震后腺苷酸的恢复不受肌红蛋白预处理的影响。如果将肾动脉闭塞(RAO)而不是电击用作缺血性挑战,则肌红蛋白对腺嘌呤核苷酸含量没有明显的影响。这项研究得出以下结论:1)由于铁的依赖性机制,肌红蛋白适度降低了基线腺苷酸库; 2)肌红蛋白通过非血流动力学/非铁依赖性机制极大地加重了休克引起的腺苷酸消耗; 3)肌红蛋白肾毒性不能仅归因于组织铁负荷; 4)RAO模型可以完全掩盖对缺血性细胞能量学的重要影响。当使用RAO模型研究缺血性ARF时,必须认识到这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号